Teyi Pharmaceutical Group Co Ltd (002728)

Currency in CNY
9.31
+0.05(+0.54%)
Closed·
002728 Scorecard
Full Analysis
Management has been aggressively buying back shares
002728 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.169.34
52 wk Range
6.7910.40
Key Statistics
Bid/Ask
9.31 / 9.31
Prev. Close
9.26
Open
9.25
Day's Range
9.16-9.34
52 wk Range
6.79-10.4
Volume
19.49M
Average Volume (3m)
19.52M
1-Year Change
19.82%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002728 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Teyi Pharmaceutical Group Co Ltd Company Profile

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular and cerebrovascular, and digestive system drugs, as well as pediatrics, dermatology, tuberculosis, respiratory, rheumatology, nephrology, and endocrinology medicines. Its chemical raw materials and products include aluminum carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. Teyi Pharmaceutical Group Co.,Ltd was founded in 2002 and is based in Taishan City, the People’s Republic of China.

Employees
1341
Market
China

Compare 002728 to Peers and Sector

Metrics to compare
002728
Peers
Sector
Relationship
P/E Ratio
108.5x30.5x−0.5x
PEG Ratio
−1.43−0.170.00
Price/Book
2.6x3.2x2.6x
Price / LTM Sales
5.7x4.9x3.3x
Upside (Analyst Target)
-15.0%43.4%
Fair Value Upside
Unlock4.8%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.00

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.08%
Dividend Yield
0.54%
Industry Median 1.51%
Annualised payout
0.05
Paid annually
5-Years Growth
-33.44%
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.06 / --
Revenue / Forecast
295.13M / --
EPS Revisions
Last 90 days

002728 Income Statement

FAQ

What Stock Exchange Does Teyi Pharmaceutical Trade On?

Teyi Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Teyi Pharmaceutical?

The stock symbol for Teyi Pharmaceutical is "002728."

What Is the Teyi Pharmaceutical Market Cap?

As of today, Teyi Pharmaceutical market cap is 4.65B.

What Is Teyi Pharmaceutical's Earnings Per Share (TTM)?

The Teyi Pharmaceutical EPS (TTM) is 0.08.

When Is the Next Teyi Pharmaceutical Earnings Date?

Teyi Pharmaceutical will release its next earnings report on 22 Oct 2025.

From a Technical Analysis Perspective, Is 002728 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Teyi Pharmaceutical Stock Split?

Teyi Pharmaceutical has split 3 times.

How Many Employees Does Teyi Pharmaceutical Have?

Teyi Pharmaceutical has 1341 employees.

What is the current trading status of Teyi Pharmaceutical (002728)?

As of 10 Aug 2025, Teyi Pharmaceutical (002728) is trading at a price of 9.31, with a previous close of 9.26. The stock has fluctuated within a day range of 9.16 to 9.34, while its 52-week range spans from 6.79 to 10.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.